Review
Accepted on 21 Apr 2025
Research Progress on m6A and Drug Resistance in Gastrointestinal Tumors Author：
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565738
Type at least 3 characters
26,224 articles
Original Research
Accepted on 21 Apr 2025
Anticancer Activity of RM-3-22: A TAZQ-Based Hydroxamic Acid Derivative Targeting NSCLC In Vitro and In Vivo
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544666
Original Research
Accepted on 21 Apr 2025
Dl-3-n-butylphthalide attenuates DOX-induced cardiotoxicity in mice by inhibiting Nrf2/Keap1 complex formation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1542296
Original Research
Accepted on 21 Apr 2025
Probiotic biofilm modified bioceramics for bone defect healing via osteogenesis, angiogenesis, and immune modulation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588023
Review
Accepted on 21 Apr 2025
Quercetin as a Therapeutic Agent for Acute Pancreatitis: A Comprehensive Review of Antioxidant, Anti-inflammatory, and Immunomodulatory Mechanisms
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1587314
Original Research
Accepted on 21 Apr 2025
Proton pump inhibitors use and risk of type 2 diabetes mellitus: correlation analysis, prediction model construction, and key genes identification
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1580090
Original Research
Accepted on 21 Apr 2025
Pan-Cancer Profiling of FZD2 as a Prognostic Biomarker: Integrative Multi-Omics Analysis with Experimental Validation and Functional Characterization in Gastric Cancer
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534974
Original Research
Accepted on 18 Apr 2025
Adherence and Persistence with Istradefylline Treatment in Patients with Parkinson's Disease in the United States
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1548631
- 273 views
Editorial
Accepted on 18 Apr 2025
Editorial: Integrative Pharmacological Approaches for Regenerating Cartilage and Bone Tissue
in Integrative and Regenerative Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613512
- 224 views
Original Research
Accepted on 18 Apr 2025
Compatibility optimization of the traditional Chinese medicines 'Eczema mixture' based on Back-Propagation Artificial Neural Network and Non-dominated Sorting Genetic Algorithm
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1593783
- 225 views
Original Research
Accepted on 18 Apr 2025
Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577201
- 240 views
Original Research
Accepted on 18 Apr 2025
The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1547142
Review
Accepted on 18 Apr 2025
Curcumin: A potential anti-photoaging agent
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559032
Original Research
Accepted on 18 Apr 2025
Beta-boswellic Acid Facilitates Diabetic Wound Healing by Targeting STAT3 and Inhibiting Ferroptosis in Fibroblasts
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578625
Original Research
Accepted on 18 Apr 2025
Adverse drug events associated with Insulin glargine: a real-world pharmacovigilance study based on the FAERS database
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563238
Review
Accepted on 18 Apr 2025
The research progress on radionuclides in osteoporosis diagnosis and drug efficacy monitoring
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594903